Updates are available Correction dated 2022-09-06
Click to view Correction: https://doi.org/10.1007/s10840-022-01367-x
-
Authors
Rajendra, Anil https://orcid.org/0000-0001-7607-1479
Hunter, Tina D.
Morales, Gustavo X.
Zei, Paul
Boo, Lee Ming
Varley, Allyson
Osorio, Jose
-
Funding
Funding for this research was provided by:
Biosense Webster
- License Information
-
More Information
Article History
Received: 25 May 2022
Accepted: 1 August 2022
First Online: 10 August 2022
Change Date: 6 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10840-022-01367-x
Declarations
:
: A Rajendra is a paid consultant for Biosense Webster, Inc.; Boston Scientific; and Philips and paid consultant and speaker for Acutus Medical. TD Hunter is an employee of CTI Clinical Trial and Consulting Services, which is a consultant to Biosense Webster, Inc. G Morales reports grants from Adagio Medical, Inc.; Acutus Medica, Inc.; Affera, Inc.; AtriCure, Inc.; Boston Scientific; Biosense Webster, Inc.; Farapulse, Inc.; Medtronic Inc.; and S2Medical and is a paid consultant for Abbott. P Zei is a paid consultant for Biosense Webster, Inc.; Abbott; Affera; and Varian and is an expert witness for Boehringer Ingelheim. LM Boo is an employee of and owns stock in Biosense Webster, Inc. A Varley is an employee of Heart Rhythm Clinical and Research Solutions, which is funded by Biosense Webster for the submitted work. J Osorio is a paid consultant for Biosense Webster, Inc.; Galaxy Medical; Medtronic; and Boston Scientific.
